Shanghai Fosun Pharmaceutical Group's Shanghai Henlius Biotech has announced the appointment of Yingbo Mao as the firm's new chief financial officer (CFO), effective from Monday, July 1, 2024.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to CorporateTreasurer.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a treasurer, CFO or senior professional at a corporate or SME, please register for free VIP access here.